Eva Renee Barnett

2023

In 2023, Eva Renee Barnett earned a total compensation of $2.1M as Chief Financial Officer at Immunovant, a 53% decrease compared to previous year.

Compensation breakdown

Bonus$414,430
Option Awards$636,078
Salary$435,000
Stock Awards$562,952
Other$21,635
Total$2,070,095

Barnett received $636.1K in option awards, accounting for 31% of the total pay in 2023.

Barnett also received $414.4K in bonus, $435K in salary, $563K in stock awards and $21.6K in other compensation.

Rankings

In 2023, Eva Renee Barnett's compensation ranked 503rd out of 2,983 executives tracked by ExecPay. In other words, Barnett earned more than 83.1% of executives.

ClassificationRankingPercentile
All
503
out of 2,983
83rd
Division
Manufacturing
289
out of 1,637
82nd
Major group
Chemicals And Allied Products
199
out of 906
78th
Industry group
Drugs
196
out of 869
77th
Industry
Biological Products, Except Diagnostic Substances
68
out of 211
68th
Source: SEC filing on June 26, 2023.

Barnett's colleagues

We found two more compensation records of executives who worked with Eva Renee Barnett at Immunovant in 2023.

2023

Peter Salzmann

Immunovant

Chief Executive Officer

2023

William Macias

Immunovant

Chief Medical Officer

News

You may also like